๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

ESTABLISHMENT AND APPLICATION OF A NORMAL RANGE FOR NUCHAL TRANSLUCENCY ACROSS THE FIRST TRIMESTER

โœ Scribed by FERGUS SCOTT; ANTHEUNIS BOOGERT; MICHAEL SINOSICH; JOHN ANDERSON


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
377 KB
Volume
16
Category
Article
ISSN
0197-3851

No coin nor oath required. For personal study only.

โœฆ Synopsis


Before chorionic villus sampling at 10-13 weeks' gestation, 453 women had the crown-rump length and nuchal translucency (NT) measured with transabdominal ultrasound. There were 19 aneuploid pregnancies (ten cases of trisomy 21, six of trisomy 18, one of 47+marker, one 47,XXX, and one 45,X mosaic). Average NT was 1.7 mm (range 0-5 mm), correlating with the crown-rump length, but not maternal age. A static cut-off of 2.5 mm gave a false-positive rate of 1.3 per cent for crown-rump length between 30 and 35 mm, rising to 13 per cent in fetuses with a crown-rump length between 50 and 65 mm. This gave an overall false-positive rate of 5.5 per cent for a detection rate of 30 per cent for trisomy 21. Applying a dynamic action limit (95th centile), the false-positive rate remained at 5 per cent irrespective of the crown-rump length, detecting 30 per cent of trisomy 21 and 36.8 per cent of all aneuploidies. Raising the action limit to the 97.5th centile halved the false-positive rate (2.5 per cent), with no change in trisomy 21 detection and only a slight decrease in aneuploidy detection (31.6 per cent). Aneuploid fetuses showed normal first-trimester growth. NT increases with gestational age, making a dynamic action limit necessary to decrease the false-positive rate, while maintaining aneuploidy detection rates. Aneuploidy does not cause significant first-trimester growth retardation, enabling normal ranges for NT with crown-rump length to apply.


๐Ÿ“œ SIMILAR VOLUMES


Increased nuchal translucency in the fir
โœ Viora, Elsa ;Sciarrone, Andrea ;Bastonero, Simona ;Errante, Giuseppe ;Campogrand ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 518 KB

Makrydimas and colleagues recently reported two cases of subcutaneous edema in the back of the fetal neck at 10-14 weeks associated with osteogenesis imperfecta [Makrydimas et al., 2001]. We report a very similar case we have observed at 13 and 16 weeks in a pregnancy without any family risk. A hea

Fetal โ€˜space-suitโ€™ hydrops in the first
โœ Lee P. Shulman; Owen P. Phillips; Donald S. Emerson; Richard E. Felker; Aviracha ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 97 KB ๐Ÿ‘ 3 views

Detecting first trimester fetuses with pan-body hydrops, giving the appearance of a 'space-suit,' is associated with a marked increased risk for chromosome abnormalities. In 30 consecutive fetuses prospectively characterized by space-suit hydrops, detected at or before 13.9 weeks' gestation, 26 (86.

NUCHAL TRANSLUCENCY CANNOT BE USED AS A
โœ L. H. KORNMAN; L. P. MORSSINK; J. R. BEEKHUIS; B. T. H. M. DE WOLF; M. P. HERING ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 732 KB

We decided to assess the practicability of introducing nuchal translucency (NT) measurements as a screening programme for fetal Down's syndrome in the first trimester of pregnancy, within the population of women who receive ultrasound examinations in our department. Over a l-year period, measurement

Screening for trisomy 21 in twin pregnan
โœ Kevin Spencer ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 61 KB ๐Ÿ‘ 1 views

In the ยฎrst trimester of pregnancy the biochemical markers free b-hCG and pregnancy associated plasma protein-A (PAPP-A) are used for the prenatal screening of trisomy 21, either alone or in combination with nuchal translucency (NT) thickness. In this study, I have analysed the distribution of these

First-trimester screening for Down syndr
โœ P. De Biasio; M. Siccardi; G. Volpe; L. Famularo; F. Santi; S. Canini ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 153 KB ๐Ÿ‘ 3 views

In a population of 1467 women attending the 'G. Gaslini' Institute for antenatal care, we evaluated first-trimester risk screening for Down syndrome using the 'combined test' based on ultrasound measurement of nuchal translucency (NT), maternal serum pregnancy-associated plasma protein A (PAPP-A) an